Barricade Therapeutics
Company profile on P2PMarketData. Barricade Therapeutics is a biotechnology company based in Fort Worth, TX, founded in 2017. It has raised $513.8K through crowdfunding on StartEngine.
Barricade Therapeutics is a biotechnology company headquartered in Fort Worth, Texas, focused on developing BT-1501, an oral investigational therapy for colorectal cancer patients with APC mutations. The company is in preclinical development stages and is preparing to advance its lead candidate into first-in-human clinical studies. Barricade's research targets a genetic mutation present in a substantial portion of colorectal cancer cases.
Frequently asked questions about Barricade Therapeutics
How much funding has Barricade Therapeutics raised?
Barricade Therapeutics has raised $513.8K through crowdfunding across 1 round tracked by P2PMarketData, from 186 investors.
What is Barricade Therapeutics' valuation?
Barricade Therapeutics had an indicative valuation of $18M in its 2026 funding round.
What is Barricade Therapeutics' revenue?
Barricade Therapeutics reported revenue of $249.9K for fiscal year 2024.
Is Barricade Therapeutics profitable?
No. Barricade Therapeutics reported a net loss of $935.7K for fiscal year 2024.
How many employees does Barricade Therapeutics have?
Barricade Therapeutics reported 1 employee for fiscal year 2024.
When was Barricade Therapeutics founded?
Barricade Therapeutics was founded in November 2017.
Where is Barricade Therapeutics based?
Barricade Therapeutics is headquartered in Fort Worth, Texas, United States, and is incorporated in Delaware, United States.
What industry is Barricade Therapeutics in?
Barricade Therapeutics operates in the Biotechnology industry within the Healthcare sector.